Method, device, equipment and storage medium for performing chromosome microdeletion analysis across breakpoints
Through cross-breakpoint analysis method, combined with gene sequencing and family linkage analysis, the problem of detection of chromosome microdeletion before embryo implantation is solved, the precise judgment of embryo chromosome microdeletion is achieved, and the success rate of assisted reproductive technology is improved.
Patent Information
- Application Number
- CN202111461943.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-02
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-12-02
AI Technical Summary
The existing preimplantation genetic diagnostic techniques of embryos cannot effectively detect and accurately locate chromosomal microdeletions, resulting in the inability to accurately determine whether the embryo carries the abnormality, affecting the success rate of implantation.
The method of chromosomal microdeletion analysis across breakpoints is used to obtain the gene sequencing results of the parent and parent, and the breakpoint location of the target missing region is determined, and the sequencing information of the reference embryo sample is combined to conduct family linkage analysis to accurately judge the embryo to be tested. chromosomal status.
Accurate analysis of embryonic chromosome microdeletion is achieved, ensuring accurate judgment of embryos before implantation, and improving the success rate of assisted reproductive technology.
Smart Images

Figure CN114220482B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of bioinformatics, and in particular to a method, device, equipment and storage medium for performing chromosome microdeletion analysis across breakpoints. Background Art
[0002] Preimplantation genetic diagnosis (PGD) is an emerging diagnostic technology developed in conjunction with assisted reproductive technology. This technology relies on cell biopsy and single-cell amplification to perform genetic tests on embryos formed by in vitro fertilization to determine their chromosome copy number variation, translocation and inversion, single gene mutation, etc., to exclude genetically abnormal embryos and implant normal embryos into the mother for continued development to improve the implantation success rate and avoid the inheritance of abnormal chromosomes or single gene genes to offspring.
[0003] Chromosomal microdeletion is a manifestation of chromosomal abnormality, but due to the small size of the deleted fragment and the insufficient resolution of traditional detection methods, the microdeletion cannot be effectively detected and precisely located. Therefore, it is impossible to accurately determine whether the embryo before implantation is a microdeletion carrier or normal. Summary of the invention
[0004] Based on this, it is necessary to provide a method, device, equipment and storage medium for performing chromosome microdeletion analysis across breakpoints to accurately determine whether the embryo is a chromosome microdeletion carrier before implantation.
[0005] A method for performing chromosome microdeletion analysis across breakpoints, comprising the steps of:
[0006] Obtain the genetic sequencing results of the father and mother;
[0007] Obtaining chromosome deletion information of at least one party based on the gene sequencing results of the father and / or mother;
[0008] Selecting one party as the target party according to the chromosome deletion information, selecting a deletion region covering the breakpoint position in one of the chromosomes of the target party as the target deletion region, obtaining sequencing information of the target party in the target deletion region, and determining the breakpoint position of the target deletion region according to the sequencing information;
[0009] Obtain sequencing information of reference embryo samples in the target deletion region;
[0010] According to the sequencing information of the target and reference embryo samples in the target deletion region, a reference embryo sample with the same breakpoint position as the target is selected as a carrier embryo;
[0011] Determine a region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position of the father, mother and carrier embryo as a target analysis region, construct haplotypes according to the genotypes of the father, mother and carrier embryo in the target analysis region to perform family linkage analysis, determine the normal haplotype and carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain the haplotype of the target party that is different from the carrier haplotype as its normal haplotype;
[0012] Obtaining the genotype of the embryo to be tested in the target analysis region and constructing the haplotype of the embryo to be tested;
[0013] The embryo to be tested having the normal haplotype of the target party is obtained as the normal embryo of the current target analysis area.
[0014] In one embodiment, determining the breakpoint position of the target deletion region according to the sequencing information comprises the steps of:
[0015] According to the reference genome, the exact location of the sequencing information on the chromosome and the number of matching sequences are obtained;
[0016] According to the number of matching sequences, the GC content of the sequencing information is corrected to obtain normalized sequencing information;
[0017] Based on the above-mentioned reference genome sequence information, the breakpoint positions of the normalized sequencing information are obtained.
[0018] In one embodiment, the gene sequencing results of the father and the mother are high-throughput sequencing results obtained using the second-generation sequencing technology.
[0019] In one embodiment, the sequencing information of the target deletion region is the Sanger sequencing result.
[0020] In one embodiment, the region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position refers to a region containing multiple SNP sites within a range of 1M to 2M upstream and downstream of the breakpoint position.
[0021] A device for performing chromosome microdeletion analysis across breakpoints, comprising:
[0022] A sequencing result acquisition module is used to obtain the gene sequencing results of the father and mother;
[0023] A deletion information acquisition module, used to obtain chromosome deletion information of at least one party according to the gene sequencing results of the father and / or the mother;
[0024] A breakpoint position acquisition module is used to select a party as a target party according to the chromosome deletion information, select a deletion region covering the breakpoint position in one of the chromosomes of the target party as a target deletion region, obtain sequencing information of the target party in the target deletion region, and determine the breakpoint position of the target deletion region according to the sequencing information;
[0025] A sequencing information acquisition module is used to obtain sequencing information of reference embryo samples in the target deletion region;
[0026] A carrier embryo acquisition module is used to select a reference embryo sample with the same breakpoint position as the target embryo as a carrier embryo based on the sequencing information of the target embryo and the reference embryo samples in the target deletion region;
[0027] A normal haplotype acquisition module is used to determine a region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position of the father, mother and carrier embryo as a target analysis region, construct haplotypes according to the genotypes of the father, mother and carrier embryo in the target analysis region to perform family linkage analysis, determine the normal haplotype and carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain the haplotype of the target party that is different from the carrier haplotype as its normal haplotype;
[0028] The embryo genotype acquisition module is used to obtain the genotype of the embryo to be tested in the target analysis area and construct the haplotype of the embryo to be tested;
[0029] The normal embryo acquisition module is used to acquire the embryo to be tested having the normal haplotype of the target party as the normal embryo of the current target analysis area.
[0030] In one of the embodiments, the breakpoint position acquisition module is used to obtain the exact position of the sequencing information on the chromosome and the number of matching sequences based on the reference genome, and to correct the GC content of the sequencing information based on the number of matching sequences to obtain the normalized sequencing information, and to obtain the breakpoint position of the normalized sequencing data based on the reference genome sequence information.
[0031] In one embodiment, the gene sequencing results of the father and the mother obtained by the sequencing result acquisition module are high-throughput sequencing results obtained using the second-generation sequencing technology.
[0032] In one embodiment, the sequencing information of the target deletion region acquired by the breakpoint position acquisition module and the information acquisition module is a Sanger sequencing result.
[0033] In one embodiment, the region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position refers to a region containing multiple SNP sites within a range of 1M to 2M upstream and downstream of the breakpoint position.
[0034] A computer device comprises a processor and a memory, wherein a computer program is stored in the memory, and when the processor executes the computer program, the steps of the above-mentioned method for analyzing chromosome microdeletion are implemented.
[0035] A computer storage medium stores a computer program, which implements the steps of the above-mentioned chromosome microdeletion analysis method when executed.
[0036] The above-mentioned method and device for performing chromosome microdeletion analysis across breakpoints analyzes the gene sequencing results of the father and the mother to obtain chromosome deletion information, analyzes the breakpoint position according to the deletion information, compares the reference embryo sample sequencing information with the deletion information, and selects the carrier embryo. According to the region containing multiple SNP sites within the preset range upstream and downstream of the breakpoint position of the father, the mother and the carrier embryo, a family linkage analysis is performed to determine the normal haplotype, and then the embryo to be tested is compared with it, so that the normal embryo can be accurately selected. The analysis method of chromosome microdeletion can accurately analyze the chromosome breakpoint, and on this basis, the chromosome deletion of the embryo can be accurately judged in combination with the SNP sites upstream and downstream of the breakpoint. The analysis method is simple to operate and the result is accurate. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 Schematic diagram of a process for analyzing chromosome microdeletions according to an embodiment of the present invention;
[0038] Figure 2 A schematic diagram of the structure of a device for analyzing chromosome microdeletions according to an embodiment of the present invention;
[0039] Figure 3 The result of maternal chromosome breakpoint calculation;
[0040] Figure 4 The results of Sanger sequencing and precise positioning of the maternal cross-breakpoint PCR products;
[0041] Figure 5 This is the Sanger sequencing result of the PCR product across the breakpoints of waste embryo 1;
[0042] Figure 6 This is the Sanger sequencing result of the PCR product across the breakpoints of waste embryo 2. DETAILED DESCRIPTION
[0043] In order to make the above-mentioned purpose, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present invention, so the present invention is not limited by the specific embodiments disclosed below.
[0044] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.
[0045] The "heterozygous deletion" mentioned in this article refers to the situation where one of the homologous chromosomes has a microdeletion; the "SNP" mentioned is single nucleotide polymorphism, which refers to the DNA sequence polymorphism caused by a single nucleotide variation (conversion, transversion, insertion and deletion, etc.) on the chromosome genome, and the variation frequency in the population is higher than 1%; the "proband" mentioned refers to the individual with chromosomal microdeletion who is first discovered in the family.
[0046] like Figure 1 As shown, the method for performing chromosome microdeletion analysis across breakpoints in one embodiment of the present invention comprises the following steps:
[0047] Step S11: Obtain the gene sequencing results of the father and the mother.
[0048] In one specific example, the gene sequencing results of the father and the mother are high-throughput sequencing results obtained using next-generation sequencing (NGS). It is understandable that in other specific examples, other methods can be used to obtain the gene sequencing results of the father and the mother, which can be sequencing results for part of the chromosome or the whole genome.
[0049] Step S12: According to the gene sequencing results of the father and / or the mother, the chromosome deletion information of at least one party is obtained.
[0050] In a specific example, when the chromosome deletion status of the father and the mother is known, the chromosome deletion information of the father and the mother can be obtained based on the gene sequencing results of the chromosome deletion of the father and the mother. It is understandable that in other specific examples, for example, when the chromosome deletion status of at least one of the father and the mother is unknown, the deletion information of one or both chromosomes can also be obtained based on the gene sequencing results of both the father and the mother.
[0051] Step S13: Select one party as the target party according to the chromosome deletion information, select the deletion region covering the breakpoint position in one of the chromosomes of the target party as the target deletion region, obtain the sequencing information of the target party in the target deletion region, and determine the breakpoint position of the target deletion region according to the sequencing information.
[0052] In a specific example, determining the breakpoint position of the target deletion region according to the sequencing information includes step S131, step S132 and step S133.
[0053] Step S131: According to the reference genome, the exact position of the sequencing information on the chromosome and the number of matching sequences are obtained.
[0054] In one of the specific examples, the sequencing information of the missing party of the father and the mother is compared with the human genome standard sequence hg19 by BWA (Burrow-Wheeler Aligner) software to determine the exact position of the sequencing information on the chromosome. The sequencing sequences with low quality, multiple matches and incomplete matches on the chromosome are removed to ensure the accuracy of the sequencing information and the uniqueness of the sequence positioning. The entire chromosome is divided into non-overlapping areas of 5kb fragment size as windows, and the number of unique matching sequences obtained on each window is calculated. It is understandable that in other specific examples, other methods are also selected to obtain the exact position of the sequencing information on the chromosome and the number of matching sequences.
[0055] Step S132: Correct the GC content of the sequencing information according to the number of matching sequences to obtain normalized sequencing information.
[0056] In a specific example, GC content deviation is corrected, windows are merged, and window data are normalized.
[0057] Step S133: Based on the reference genome sequence information, the breakpoint positions of the normalized sequencing information are obtained.
[0058] In a specific example, the normalized sequencing information is compared with the human reference genome data, log2RR is calculated, the breakpoints are calculated by lumpy software, the breakpoints are roughly located, and finally the breakpoint coordinates are determined by IGV (Integrative Genomics Viewer) software. It is understandable that in other specific examples, other methods can also be used to obtain the breakpoint positions of chromosome microdeletions. Specifically, the "RR" in "log2RR" refers to the ratio of Read1 to Read2, Read1 is the number of Reads of the sample, Read2 is the number of Reads of the reference library, and the "Read" is the sequencing sequence generated by a high-throughput sequencing platform (such as various second-generation sequencing platforms).
[0059] It is understandable that, in other specific examples, other existing data analysis methods may be used to determine the breakpoint position of the target deletion region based on the sequencing information.
[0060] Step S14: Obtain sequencing information of the reference embryo sample in the target deletion region.
[0061] In a specific example, the sequencing information of the target deletion region is a Sanger sequencing result. It is understandable that in other specific examples, other sequencing methods can also be used to obtain the sequencing information of the target deletion region.
[0062] In a specific example, before obtaining the sequencing information of the target deletion region, a step of designing cross-breakpoint primers is also included. Specifically, an upstream primer is designed at the upstream sequence of the breakpoint position, and a downstream primer is designed at the downstream sequence, wherein the upstream sequence and the downstream sequence include sequences within a 2.5 kb error range from the breakpoint position, and the software or website used to design primers can be, but is not limited to, Primer3, Primer5, Oligo 6, and Oligo 7, etc.
[0063] Step S15: Based on the sequencing information of the target and reference embryo samples in the target deletion region, a reference embryo sample having the same breakpoint position as the target is selected as a carrier embryo.
[0064] In a specific example, when there are waste embryos in the embryos, the reference embryo can be a waste embryo. It is understandable that in other specific examples, for example, when there are no waste embryos, other embryos can also be directly used as reference embryos.
[0065] Using waste embryos as reference embryos can make reasonable and full use of waste resources. In addition, in actual PGD, the probability of detecting carrier embryos is very high, and the use of carrier embryos is also a full use of resources.
[0066] Step S16: Determine the region containing multiple SNP sites within the preset range upstream and downstream of the breakpoint position of the father, the mother and the carrier embryo as the target analysis region, construct haplotypes according to the genotypes of the father, the mother and the carrier embryo in the target analysis region, respectively, and perform family linkage analysis, determine the normal haplotype and the carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain the haplotype of the target party that is different from the carrier haplotype as its normal haplotype.
[0067] In a specific example, the region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position refers to a region containing multiple SNP sites within a range of 1M to 2M upstream and downstream of the breakpoint position.
[0068] In a specific example, constructing a haplotype based on a carrier embryo may be constructing a haplotype based on one carrier embryo or may be constructing a haplotype based on multiple carrier embryos.
[0069] Constructing haplotypes based on multiple carrier embryos can serve to verify each other among the carrier embryos, and can more accurately determine the normal haplotype and carrier haplotype of the carrier embryos.
[0070] Step S17: Obtain the genotype of the embryo to be tested in the target analysis region and construct the haplotype of the embryo to be tested.
[0071] Step S18: Acquire the embryo to be tested having the normal haplotype of the target party as the normal embryo of the current target analysis area.
[0072] Based on the same idea as the above method, Figure 2 As shown, the present invention also provides a device 20 for performing chromosome microdeletion analysis across breakpoints, which includes a sequencing result acquisition module 21, a deletion information acquisition module 22, a breakpoint position acquisition module 23, a sequencing information acquisition module 24, a carrier embryo acquisition module 25, a normal haplotype acquisition module 26, an embryo genotype acquisition module 27 and a normal embryo acquisition module 28.
[0073] Specifically, the sequencing result acquisition module 21 is used to obtain the gene sequencing results of the father and the mother.
[0074] The deletion information acquisition module 22 is used to obtain the chromosome deletion information of at least one party according to the gene sequencing results of the father and / or the mother.
[0075] The breakpoint position acquisition module 23 is used to select one party as the target party according to the chromosome deletion information, select the deletion region covering the breakpoint position in one of the chromosomes of the target party as the target deletion region, obtain the sequencing information of the target party in the target deletion region, and determine the breakpoint position of the target deletion region according to the sequencing information.
[0076] The sequencing information acquisition module 24 is used to obtain the sequencing information of the reference embryo sample in the target deletion region.
[0077] The carrier embryo acquisition module 25 is used to select a reference embryo sample having the same breakpoint position as the target embryo as a carrier embryo based on the sequencing information of the target embryo and the reference embryo sample in the target deletion region.
[0078] The normal haplotype acquisition module 26 is used to determine the region containing multiple SNP sites within the preset range upstream and downstream of the breakpoint position of the father, the mother and the carrier embryo as the target analysis region, construct haplotypes according to the genotypes of the father, the mother and the carrier embryo in the target analysis region to perform family linkage analysis, determine the normal haplotype and the carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain the haplotype of the target party that is different from the carrier haplotype as its normal haplotype.
[0079] The embryo genotype acquisition module 27 is used to obtain the genotype of the embryo to be tested in the target analysis area and construct the haplotype of the embryo to be tested.
[0080] The normal embryo acquisition module 28 is used to acquire the embryo to be tested having the normal haplotype of the target party as the normal embryo of the current target analysis area.
[0081] In a specific example, the above-mentioned breakpoint position acquisition module is used to obtain the exact position of the sequencing information on the chromosome and the number of matching sequences based on the reference genome, and correct the GC content of the sequencing information based on the number of matching sequences, obtain the normalized sequencing information, and obtain the breakpoint position of the normalized sequencing data based on the above-mentioned reference genome sequence information. It can be understood that in other specific examples, the data of the breakpoint position acquisition module can be obtained by analyzing the data input obtained by other data analysis methods.
[0082] Based on the embodiments described above, the present invention also provides a computer device that can be used for chromosome microdeletion analysis, comprising a processor and a memory, wherein a computer program is stored in the memory, and when the processor executes the computer program, the steps of the chromosome microdeletion analysis method in any of the above embodiments and specific examples are implemented.
[0083] Accordingly, the present invention also provides a computer storage medium that can be used for chromosome microdeletion analysis, on which a computer program is stored, and when the computer program is executed, the steps of the chromosome microdeletion analysis method of any of the above embodiments are implemented.
[0084] Those of ordinary skill in the art will appreciate that all or part of the processes in the above method can be implemented by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium, and the computer program, when executed, can include the processes of the embodiments of the above methods. Among them, any reference to memory, storage, database or other media used in the embodiments provided in the present application includes at least one of non-volatile and volatile memory. Non-volatile memory may include read-only memory (ROM), magnetic tape, floppy disk, flash memory or optical memory, etc. Volatile memory may include random access memory (RAM) or external cache memory. As an illustration and not limitation, RAM can be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM).
[0085] In order to illustrate the technical effect of the chromosome microdeletion analysis method of the present invention, a PGD embryo chromosome microdeletion analysis is used as a case analysis.
[0086] This case recruited a family with heterozygous chromosome deletion who were ready to undergo PGD testing. As shown in Table 1, the mother was a patient with heterozygous chromosome deletion and the father was normal.
[0087] Table 1
[0088] serial number Family lineage Gene mutation type 1 maternal side Heterozygous deletion (chr22:30032623~30127458) 2 paternal side Not seen
[0089] Peripheral blood samples from the father and mother and single-cell whole genome amplification product samples of their two waste embryos and five embryos were used. The whole genome amplification product samples of the waste embryos were named waste embryo 1 and waste embryo 2, and the whole genome amplification product samples of the embryos were named embryo 1 to embryo 5. Parental genomic DNA was extracted using a DNA extraction kit (TIANGEN, catalog number: DP304). After extraction, the specific steps for chromosome microdeletion analysis were as follows:
[0090] 1. High-throughput sequencing of paternal and maternal genomic DNA (steps (1) to (7) refer to patent: A method for constructing a nucleic acid library and its application in analyzing chromosome structural abnormalities in preimplantation embryos (application number: 202011094180.6))
[0091] (1) DNA fragmentation
[0092] a. Prepare 500 ng DNA and add water to 17 μL. Prepare the enzyme digestion mixture Mix 1 according to Table 2. Add 3 μL of the enzyme digestion mixture Mix 1 to the sample, mix well with a pipette, and centrifuge briefly.
[0093] Table 2
[0094] Enzyme Digestion Mix 1 Component Volume(uL) Endonuclease reaction buffer 2 Endonuclease 1, NspI 0.5 Endonuclease 2, MboI 0.5 Total volume 3
[0095] b. Place the centrifuged DNA into a PCR instrument and set the PCR instrument program as shown in Table 3.
[0096] Table 3
[0097] step temperature time 1 37℃ 15min 2 65℃ 20min 3 4℃ Hold
[0098] (2) Connector connection (Huada platform)
[0099] a. Prepare adapter mixture Mix 2 according to Table 4, add 5 μL adapter mixture Mix 2 to the digested DNA, mix well with a pipette, and centrifuge briefly.
[0100] Table 4
[0101] Components of Mix2 Volume (μL) Connector 1 2.5 Connector 2 2.5 Total volume 5
[0102] b. Place the centrifuged DNA into a PCR instrument and set the PCR instrument program as shown in Table 5.
[0103] Table 5
[0104] step temperature time 1 65℃ 10min 2 4℃ Hold
[0105] c. Prepare ligase mixture Mix3 according to Table 6, add 5 μL of ligase mixture Mix3 to the above-mentioned adapter DNA, mix well with a gun (do not vortex), and centrifuge briefly.
[0106] Table 6
[0107]
[0108]
[0109] d. Place the centrifuged DNA into a PCR instrument and set the PCR instrument program as shown in Table 8.
[0110] Table 8
[0111] step temperature time 1 22℃ 15min 2 65℃ 10min 3 4℃ Hold
[0112] (3) Fragment screening
[0113] Add water to make up to 100 μL of the DNA sample after the connector connection obtained in step (2), then add 60 μL of AMPure XP magnetic beads, mix with a gun, leave at room temperature for 5 minutes, place on a magnetic rack, wait for the liquid to become clear, transfer the supernatant to a new EP tube, add 20 μL of AMPure XP magnetic beads, leave at room temperature for 5 minutes, place on a magnetic rack, wait for the liquid to become clear, remove the supernatant, wash with 200 μL of 80% alcohol by volume, dry at room temperature, and elute with 22 μL Low TE.
[0114] (4) Concentration determination
[0115] 2 μL of sample was drawn and the concentration was measured using Qubit.
[0116] (5) PCR amplification
[0117] a. Prepare PCR reaction mixture Mix 4 according to Table 9.
[0118] Table 9
[0119] Mix4 components Volume (μL) PCR amplification enzyme 25 Universal primers 1.25 Nuclease-free water 2.5 Total volume 28.75
[0120] b. According to the concentration measurement results, take 10ng DNA sample after fragment screening, add water to 20μL and put it into a PCR tube, add 28.75μL PCR reaction mixture Mix4, then add 1.25μL of specific primers containing barcode, mix and centrifuge briefly. Put it into the PCR instrument and set the program as shown in Table 10.
[0121] Table 10
[0122]
[0123] (6) Library purification
[0124] After the reaction in step (5) is completed, centrifuge briefly, add 50 μL of AMPure XP magnetic beads, mix well with a pipette, leave at room temperature for 5 min, place on a magnetic rack, wait until the liquid becomes clear, remove the supernatant, wash with 200 μL of 80% alcohol, repeat once, dry the magnetic beads at room temperature, resuspend the magnetic beads with 40 μL Low TE, and elute the DNA.
[0125] (7) Concentration determination
[0126] 2 μL of sample was drawn and the concentration was measured using Qubit.
[0127] (8) The PCR enrichment products were sequenced on the BGI platform (MGI-200). The sequencing quality control results are shown in Table 11.
[0128] Table 11
[0129]
[0130] 2. Calculate the chromosome breakpoint positions of the father and mother
[0131] The gene sequences obtained by sequencing the father and mother were aligned with the human genome standard sequence hg19 by BWA (Burrow-Wheeler Aligner) software to determine the exact position of each sequence obtained by sequencing on the chromosome. The low-quality, multi-matched and incompletely matched sequences on the chromosome were removed to ensure the accuracy of the sequencing data and the uniqueness of the positioning of each sequence. The entire chromosome was divided into non-overlapping regions of 5kb fragment size as windows, and the number of unique matching sequences obtained on each window was calculated. The GC content deviation was corrected, the windows were merged, and the window data was normalized. Compared with the reference data, the log2RR was calculated, the breakpoints were calculated by lumpy software, the breakpoints were located, and finally the breakpoint coordinates were determined by IGV (Integrative Genomics Viewer) software.
[0132] The breakpoint position calculation result is as follows Figure 3 After data analysis, it was found that the abnormal region of the maternal chromosome was chr22: 30060000-30150000, and the error range of the upstream and downstream breakpoints was 2.5 kb each.
[0133] 3. Design of primers spanning the breakpoints
[0134] Primer5 was used to design primers, and an upstream primer was designed at the upstream sequence of the breakpoint position, and a downstream primer was designed at the downstream sequence, wherein the upstream sequence and the downstream sequence included sequences within a 2.5 kb error range from the breakpoint position. The designed primers are shown in Table 12.
[0135] Table 12
[0136] Primer name Primer sequences Upstream primer 5'-TCACCAACAGTGCATCTCCC-3' Downstream primer 5'-ACCCTGCTATTTCCTTGGGC-3'
[0137] 4. Perform cross-breakpoint PCR amplification on maternal genomic DNA amplification products
[0138] (1) Using the breakpoint-spanning primers designed in the above steps, use a kit ( Max Super-Fidelity DNA Polymerase (Novozyme, P505-d1)) was used to prepare the reaction solution on an ice box as shown in Table 13. After the preparation was completed, the solution was vortexed and centrifuged instantly.
[0139] Table 13
[0140]
[0141] (2) Place the prepared reaction solution in a PCR instrument, select 105°C as the hot cover temperature, and set the reaction parameters according to Table 14.
[0142] Table 14
[0143]
[0144] 5. Sanger sequencing of maternal genome cross-breakpoint amplification products and precise location of breakpoints
[0145] The above-mentioned cross-breakpoint amplification products were subjected to Sanger sequencing, and the maternal chromosome breakpoint position was accurately located based on the Sanger sequencing results. Figure 4 The abnormal chromosome region is chr22: 30127946-30022548, and the total length of the deleted fragment is 105 kb.
[0146] 6. PCR amplification across breakpoints of waste embryos and embryonic whole genome amplification products
[0147] (1) Using the breakpoint-spanning primers designed in step 3 above, prepare the reaction solution on ice as shown in Table 15. After preparation, vortex and centrifuge instantly.
[0148] Table 15
[0149]
[0150] (2) Place the prepared reaction solution in a PCR instrument, select 105°C as the hot cover temperature, and set the reaction parameters according to Table 16.
[0151] Table 16
[0152]
[0153]
[0154] 7. Sanger sequencing of the amplified products across the breakpoints of the waste embryo genome
[0155] The genomic DNA amplification products across the breakpoints of waste embryo 1 and waste embryo 2 were sequenced by Sanger sequencing, and the results were as follows: Figure 5 and Figure 6 According to the Sanger sequencing results of the waste embryos, compared with the Sanger sequencing results of the maternal samples in step 5, it can be found that both waste embryos 1 and 2 are embryos carrying chromosome microdeletions.
[0156] 8. Genetic linkage analysis
[0157] Both waste embryos were carrier embryos and could serve as probands. Genetic linkage analysis was performed by combining the 2M SNP loci upstream and downstream of the precise breakpoint to construct the haplotype.
[0158] The results of genetic linkage analysis of two waste embryos are as follows: waste embryo 1 is used as the proband, and its upstream and downstream effective SNP sites are 46, as shown in Table 17; waste embryo 2 is used as the proband, and its upstream and downstream effective SNP sites are 45, as shown in Table 18; waste embryo 1 and waste embryo 2 have 29 upstream and downstream effective SNP sites in total, and the constructed haplotypes are consistent. Three of the five biopsied embryos were detected to be normal.
[0159] Table 17
[0160] Sample name Number of upstream effective SNP sites Number of downstream effective SNP sites Waste embryo 1 33 13 Waste embryo 2 22 7 Embryo 1 5 7 Embryo 2 14 6 Embryo 3 18 8 Embryo 4 8 8 Embryo 5 8 7
[0161] Table 18
[0162]
[0163]
[0164] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0165] The above-described embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for those of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. It should be understood that the technical solutions obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided by the present invention are all within the protection scope of the claims attached to the present invention. Therefore, the protection scope of the patent of the present invention shall be based on the attached claims, and the description and drawings may be used to interpret the contents of the claims.
Claims
1. A method for performing chromosome microdeletion analysis across breakpoints of embryos for assisted reproduction before embryo implantation, characterized in that: Includes steps: Obtain the genetic sequencing results of the father and mother; Obtaining chromosome deletion information of at least one party based on the gene sequencing results of the father and / or mother; Selecting one party as the target party according to the chromosome deletion information, selecting a deletion region covering the breakpoint position in one of the chromosomes of the target party as the target deletion region, obtaining sequencing information of the target party in the target deletion region, and determining the breakpoint position of the target deletion region according to the sequencing information; Obtaining sequencing information of the reference embryo sample in the target deletion region; According to the sequencing information of the target party and the reference embryo sample in the target deletion region, a reference embryo sample having the same breakpoint position as the target party is selected as a carrier embryo; Determine a region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position of the father, the mother and the carrier embryo as a target analysis region, construct haplotypes according to the genotypes of the father, the mother and the carrier embryo in the target analysis region to perform family linkage analysis, determine a normal haplotype and a carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain a haplotype of the target party that is different from the carrier haplotype as its normal haplotype; Obtaining the genotype of the embryo to be tested in the target analysis region, and constructing a haplotype of the embryo to be tested; Acquire the embryo to be tested with the normal haplotype of the target party as the normal embryo of the current target analysis area; The reference embryo sample is a waste embryo from the same batch of embryos as the embryo to be tested; The father and mother of the reference embryo sample and the embryo to be tested are the same; The region containing multiple SNP sites within the preset range upstream and downstream of the breakpoint position refers to the region containing multiple SNP sites within the range of 1M to 2M upstream and downstream of the breakpoint position.
2. The method according to claim 1, characterized in that Determining the breakpoint position of the target deletion region according to the sequencing information comprises the steps of: According to the reference genome, obtaining the exact position of the sequencing information on the chromosome and the number of matching sequences; According to the number of matching sequences, the GC content of the sequencing information is corrected to obtain normalized sequencing information; Based on the reference genome sequence information, the breakpoint positions of the normalized sequencing information are obtained.
3. The method according to claim 1, characterized in that The gene sequencing results of the father and mother are high-throughput sequencing results obtained using the second-generation sequencing technology; and / or The sequencing information of the target deletion region is the Sanger sequencing result.
4. A device for performing chromosome microdeletion analysis across breakpoints of embryos for assisted reproduction before embryo implantation, characterized in that: include: A sequencing result acquisition module is used to obtain the gene sequencing results of the father and mother; A deletion information acquisition module, used to obtain chromosome deletion information of at least one party according to the gene sequencing results of the father and / or the mother; a breakpoint position acquisition module, configured to select a party as a target party according to the chromosome deletion information, select a deletion region covering the breakpoint position in one of the chromosomes of the target party as a target deletion region, obtain sequencing information of the target party in the target deletion region, and determine the breakpoint position of the target deletion region according to the sequencing information; A sequencing information acquisition module, used to obtain sequencing information of the reference embryo sample in the target deletion region; A carrier embryo acquisition module, used to select a reference embryo sample having the same breakpoint position as the target embryo as a carrier embryo according to the sequencing information of the target embryo and the reference embryo sample in the target deletion region; A normal haplotype acquisition module is used to determine a region containing multiple SNP sites within a preset range upstream and downstream of the breakpoint position of the father, mother and carrier embryo as a target analysis region, construct haplotypes according to the genotypes of the father, mother and carrier embryo in the target analysis region to perform family linkage analysis, determine the normal haplotype and carrier haplotype of the carrier embryo according to the haplotype of the non-target party, and obtain the haplotype of the target party that is different from the carrier haplotype as its normal haplotype; An embryo genotype acquisition module is used to acquire the genotype of the embryo to be tested in the target analysis region and construct a haplotype of the embryo to be tested; A normal embryo acquisition module is used to acquire an embryo to be tested having a normal haplotype of the target party as a normal embryo in the current target analysis area; The reference embryo sample is a waste embryo from the same batch of embryos as the embryo to be tested; The father and mother of the reference embryo sample and the embryo to be tested are the same; The region containing multiple SNP sites within the preset range upstream and downstream of the breakpoint position refers to the region containing multiple SNP sites within the range of 1M to 2M upstream and downstream of the breakpoint position.
5. The device according to claim 4, characterized in that The breakpoint position acquisition module is used to obtain the exact position of the sequencing information on the chromosome and the number of matching sequences based on the reference genome, and to correct the GC content of the sequencing information based on the number of matching sequences to obtain the normalized sequencing information, and to obtain the breakpoint position of the normalized sequencing information based on the reference genome sequence information.
6. The device according to claim 4, characterized in that The gene sequencing results of the father and the mother obtained by the sequencing result acquisition module are high-throughput sequencing results obtained using the second-generation sequencing technology; and / or The sequencing information of the target deletion region acquired by the breakpoint position acquisition module and the information acquisition module is the Sanger sequencing result.
7. A computer device, characterized in that: The invention comprises a processor and a memory, wherein the memory stores a computer program, and when the processor executes the computer program, the steps of the method for analyzing chromosome microdeletion according to any one of claims 1 to 3 are implemented.
8. A computer storage medium having a computer program stored thereon, characterized in that: When the computer program is executed, the steps of the method for analyzing chromosome microdeletions according to any one of claims 1 to 3 are implemented.
